FDA authorizes new use of test, first to identify the emerging pathogen Candida auris

The U.S. Food and Drug Administration authorized the first test to identify the emerging pathogenCandida auris (C. auris), which can cause serious infections in hospitalized patients. Specifically, the FDA permitted marketing for a new use of the BRUKER MALDI Biotyper CA system for the identification of C. auris, adding to the system's already cleared uses for the identification ["]

The post FDA authorizes new use of test, first to identify the emerging pathogen Candida auris appeared first on Outbreak News Today.